Your kidneys can quietly lose most of their work before you ever feel anything is wrong, and the signs that do slip through ...
A computational and synthesis study prioritized benzohydrazide compounds 3d and 3f for experimental EGFR testing, while the lack of biological assays means their binding and anticancer activity remain ...
A review identifies post-endocytic routing as the decisive step in targeted lysosomal degradation and proposes a five-tier ...
Several Oncology Catalysts, One Earnings Question AstraZeneca PLC (NYSE:AZN) enters the3-27 European Society for Medical ...
Dr. Norah Terrault, Chief of Gastroenterology & Hepatology, USC Keck Medical Center, said: “This is the start of a new era in treating people living with CHB. Bepirovirsen offers patients the ...
FURTHER shows firmonertinib 240 mg achieved 68% ORR and 16-month PFS in advanced EGFR PACC-mutant NSCLC, with intracranial ...
October 2026You were told your "kidneys are fine," but can you really rest easy?The "Creatinine" and "eGFR" columns on your ...
KRAS- and ALK-driven lung cancer models, supporting mutation-agnostic development as monotherapy and in combination with established ...
While smoking tobacco is the largest risk factor for lung cancer, up to 20 percent of diagnoses occur in nonsmokers. There ...
The EuroSCORE II seems to overestimate surgical risk by 26%, but the new EuroSCORE 3 may offer a better option.
Routine lab work helps establish a baseline, monitor metabolic and organ health, catch problems early, and show health factors beyond just the scale. Before prescribing an antiobesity medication, ...
Newspoint on MSN
HbA1c drops from 11.2% to 8.1%: Is diabetes under control? Doctor explains next steps
A reduction in HbA1c from 11.2% to 8.1% signals a meaningful improvement in average blood glucose levels. However, the lower ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results